In Silico insight into potent of anthocyanin regulation of FKBP52 to prevent Alzheimer's disease

Evidence-based Complementary and Alternative Medicine

Volumn 2014, Issue , 2014, Pages

  Hung, Tzu Chieh ^a   Chang, Tung Ti ^b   Fan, Ming Jen ^a,b   Lee, Cheng Chun ^c   Chen, Calvin Yu Chian ^a,c  

^a ASIA UNIVERSITY   (Taiwan)

^b CHINA MEDICAL UNIVERSITY   (Taiwan)

^c CHINA MEDICAL UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

ANTHOCYANIN; CYANIDIN 3 GLUCOSIDE; CYTOCHROME P450 2C9; DELPHINIDIN 3 GLUCOSIDE; FK 506 BINDING PROTEIN; FK 506 BINDING PROTEIN 52; MALVIDIN 3 GLUCOSIDE; PELARGONIDIN 3 GLUCOSIDE; PEONIDIN 3 GLUCOSIDE; PETUNIDIN 3 GLUCOSIDE; TACROLIMUS; TAU PROTEIN; UNCLASSIFIED DRUG;

ALZHEIMER DISEASE; AMINO ACID SEQUENCE; ARTICLE; COMPUTER MODEL; CONTROLLED STUDY; DRUG BINDING; DRUG EFFECT; HYDROGEN BOND; MOLECULAR DOCKING; MOLECULAR DYNAMICS; PROTEIN AGGREGATION; PROTEIN INTERACTION; PROTEIN STRUCTURE;

EID: 84901768826     PISSN: 1741427X     EISSN: 17414288     Source Type: Journal    
DOI: 10.1155/2014/450592     Document Type: Article

References (99)

1. Alzheimer's Disease International,. World Alzheimer Report 2009, 2009, http://www.alz.co.uk/research/world-report
2. Wimo A., Prince M.,. World Alzheimer Report 2010: The Global Economic Impact of Dementia, 2010, http://www.alz.co.uk/research/world-report-2012
3. Clarke N. A., Francis P. T., Cholinergic and glutamatergic drugs in Alzheimer's disease therapy. Expert Review of Neurotherapeutics 2005 5 5 671 682 2-s2.0-26444494892 10.1586/14737175.5.5.671 (Pubitemid 41431426)
4. Voisin T., Vellas B., Diagnosis and treatment of patients with severe Alzheimer's disease. Drugs and Aging 2009 26 2 135 144 2-s2.0-60249095437 10.2165/0002512-200926020-00005
5. Babiloni C., Del Percio C., Bordet R., Effects of acetylcholinesterase inhibitors and memantine on resting-state electroencephalographic rhythms in Alzheimer's disease patients. Clinical Neurophysiology: Official Journal of the International Federation of Clinical Neurophysiology 2013 124 5 837 850 10.1016/j.clinph.2012.09.017
6. Francis P. T., Ramírez M. J., Lai M. K., Neurochemical basis for symptomatic treatment of Alzheimer's disease. Neuropharmacology 2010 59 4-5 221 229 2-s2.0-77950240594 10.1016/j.neuropharm.2010.02.010
7. Mangialasche F., Solomon A., Winblad B., Mecocci P., Kivipelto M., Alzheimer's disease: clinical trials and drug development. The Lancet Neurology 2010 9 7 702 716 2-s2.0-77953518555 10.1016/S1474-4422(10)70119-8
8. Duyckaerts C., Delatour B., Potier M., Classification and basic pathology of Alzheimer disease. Acta Neuropathologica 2009 118 1 5 36 2-s2.0-67349143998 10.1007/s00401-009-0532-1
9. Lin D.-Y., Tsai F.-J., Tsai C.-H., Huang C.-Y., Mechanisms governing the protective effect of 17 β -estradiol and estrogen receptors against cardiomyocyte injury. Biomedicine 2011 1 1 21 28 2-s2.0-80955174810 10.1016/j.biomed.2011.10.004
10. Lee C.-C., Tsai C.-H., Wan L., Increased incidence of Parkinsonism among Chinese with β -glucosidase mutation in central Taiwan. BioMedicine 2013 3 2 92 94
11. Wang C.-H., Lin W.-D., Bau D.-T., Appearance of acanthosis nigricans may precede obesity: an involvement of the insulin/IGF receptor signaling pathway. BioMedicine 2013 3 2 82 87
12. Chang Y.-M., Velmurugan B. K., Kuo W.-W., Inhibitory effect of alpinate Oxyphyllae fructus extracts on Ang II-induced cardiac pathological remodeling-related pathways in H9c2 cardiomyoblast cells. BioMedicine 2013 3 4 148 152
13. Chou I. C., Lin W.-D., Wang C.-H., Association analysis between Tourette's syndrome and two dopamine genes (DAT1, DBH) in Taiwanese children. BioMedicine 2013 3 2 88 91
14. Lin W.-Y., Liu H.-P., Chang J.-S., Genetic variations within the PSORS1 region affect Kawasaki disease development and coronary artery aneurysm formation. BioMedicine 2013 3 2 73 81
15. Chambraud B., Sardin E., Giustiniani J., Dounane O., Schumacher M., Goedert M., Baulieu E., A role for FKBP52 in Tau protein function. Proceedings of the National Academy of Sciences of the United States of America 2010 107 6 2658 2663 2-s2.0-77249177547 10.1073/pnas.0914957107
16. Giustiniani J., Sineus M., Sardin E., Dounane O., Panchal M., Sazdovitch V., Duyckaerts C., Chambraud B., Baulieu E., Decrease of the immunophilin FKBP52 accumulation in human brains of alzheimer's disease and FTDP-17. Journal of Alzheimer's Disease 2012 29 2 471 483 2-s2.0-84859392758 10.3233/JAD-2011-111895
17. Koren J. III, Jinwal U. K., Davey Z., Kiray J., Arulselvam K., Dickey C. A., Bending tau into shape: the emerging role of peptidyl-prolyl isomerases in tauopathies. Molecular Neurobiology 2011 44 1 65 70 2-s2.0-79960202817 10.1007/s12035-011-8182-4
18. Cao W., Konsolaki M., FKBP immunophilins and Alzheimer's disease: a chaperoned affair. Journal of Biosciences 2011 36 3 493 498 2-s2.0-80054828829 10.1007/s12038-011-9080-7
19. Storer C. L., Dickey C. A., Galigniana M. D., Rein T., Cox M. B., FKBP51 and FKBP52 in signaling and disease. Trends in Endocrinology and Metabolism 2011 22 12 481 490 2-s2.0-82555167019 10.1016/j.tem.2011.08.001
20. Chambraud B., Belabes H., Fontaine-Lenoir V., Fellous A., Baulieu E. E., The immunophilin FKBP52 specifically binds to tubulin and prevents microtubule formation. FASEB Journal 2007 21 11 2787 2797 2-s2.0-34548485298 10.1096/fj.06-7667com (Pubitemid 47372746)
21. Davies T. H., Sánchez E. R., FKBP52. International Journal of Biochemistry and Cell Biology 2005 37 1 42 47 2-s2.0-4644318581 10.1016/j.biocel.2004.03.013 (Pubitemid 39286022)
22. Lu K. P., Liou Y., Zhou X. Z., Pinning down proline-directed phosphorylation signaling. Trends in Cell Biology 2002 12 4 164 172 2-s2.0-0036535975 10.1016/S0962-8924(02)02253-5 (Pubitemid 34442238)
23. Lu K. P., Zhou X. Z., The prolyl isomerase PIN1: a pivotal new twist in phosphorylation signalling and disease. Nature Reviews Molecular Cell Biology 2007 8 11 904 916 2-s2.0-35448945269 10.1038/nrm2261 (Pubitemid 47622559)
24. Ruan B., Pong K., Jow F., Bowlby M., Crozier R. A., Liu D., Liang S., Chen Y., Mercado M. L., Feng X., Bennett F., Von Schack D., McDonald L., Zaleska M. M., Wood A., Reinhart P. H., Magolda R. L., Skotnicki J., Pangalos M. N., Koehn F. E., Carter G. T., Abou-Gharbia M., Graziani E. I., Binding of rapamycin analogs to calcium channels and FKBP52 contributes to their neuroprotective activities. Proceedings of the National Academy of Sciences of the United States of America 2008 105 1 33 38 2-s2.0-38349090475 10.1073/pnas.0710424105
25. Liu J., Farmer J. D. Jr., Lane W. S., Friedman J., Weissman I., Schreiber S. L., Calcineurin is a common target of cyclophilin-cyclosporin A and FKBP-FK506 complexes. Cell 1991 66 4 807 815 2-s2.0-0025893168 10.1016/0092-8674(91)90124-H (Pubitemid 121001714)
26. Kissinǵer C. R., Parge H. E., Knighton D. R., Lewis C. T., Pelletier L. A., Tempczyk A., Kalish V. J., Tucker K. D., Showalter R. E., Moomaw E. W., Gastinel L. N., Habuka N., Chen X., Maldonado F., Barker J. E., Bacquet R., Villafranca J. E., Crystal structures of human calcineurin and the human FKBP12-FK506-calcineurin complex. Nature 1995 378 6557 641 644 2-s2.0-0028848524 10.1038/378641a0 (Pubitemid 3005789)
27. Reese L. C., Laezza F., Woltjer R., Taglialatela G., Dysregulated phosphorylation of Ca2+/calmodulin-dependent protein kinase II- α in the hippocampus of subjects with mild cognitive impairment and Alzheimer's disease. Journal of Neurochemistry 2011 119 4 791 804 2-s2.0-80054802256 10.1111/j.1471-4159.2011.07447.x
28. Davies T. H., Ning Y., Sánchez E. R., Differential control of glucocorticoid receptor hormone-binding function by tetratricopeptide repeat (TPR) proteins and the immunosuppressive ligand FK506. Biochemistry 2005 44 6 2030 2038 2-s2.0-13544267438 10.1021/bi048503v (Pubitemid 40223631)
29. Galigniana M. D., Erlejman A. G., Monte M., Gomez-Sanchez C., Piwien-Pilipuk G., The hsp90-FKBP52 complex links the mineralocorticoid receptor to motor proteins and persists bound to the receptor in early nuclear events. Molecular and Cellular Biology 2010 30 5 1285 1298 2-s2.0-76749092246 10.1128/MCB.01190-09
30. Cioffi D. L., Hubler T. R., Scammell J. G., Organization and function of the FKBP52 and FKBP51 genes. Current Opinion in Pharmacology 2011 11 4 308 313 2-s2.0-80051663514 10.1016/j.coph.2011.03.013
31. Quintá H. R., Galigniana M. D., The neuroregenerative mechanism mediated by the Hsp90-binding immunophilin FKBP52 resembles the early steps of neuronal differentiation. British Journal of Pharmacology 2012 166 2 637 649 2-s2.0-84859919523 10.1111/j.1476-5381.2011.01783.x
32. Quintá H. R., Maschi D., Gomez-Sanchez C., Piwien-Pilipuk G., Galigniana M. D., Subcellular rearrangement of hsp90-binding immunophilins accompanies neuronal differentiation and neurite outgrowth. Journal of Neurochemistry 2010 115 3 716 734 2-s2.0-78651322182 10.1111/j.1471-4159.2010. 06970.x
33. Castañeda-Ovando A., Pacheco-Hernández M. D. L., Páez-Hernández M. E., Rodríguez J. A., Galán-Vidal C. A., Chemical studies of anthocyanins: a review. Food Chemistry 2009 113 4 859 871 2-s2.0-56149124240 10.1016/j.foodchem.2008.09.001
34. Stintzing F. C., Carle R., Functional properties of anthocyanins and betalains in plants, food, and in human nutrition. Trends in Food Science and Technology 2004 15 1 19 38 2-s2.0-0346433433 10.1016/j.tifs.2003.07.004 (Pubitemid 38024769)
35. Kong J. M., Chia L. S., Goh N. K., Chia T. F., Brouillard R., Analysis and biological activities of anthocyanins. Phytochemistry 2003 64 5 923 933 2-s2.0-0142089791 10.1016/S0031-9422(03)00438-2 (Pubitemid 37295344)
36. Percival S. S., Grape consumption supports immunity in animals and humans. Journal of Nutrition 2009 139 supplement 9 1801S 1805S 2-s2.0-69549138060 10.3945/jn.109.108324
37. Zhao C., Giusti M. M., Malik M., Moyer M. P., Magnuson B. A., Effects of commercial anthocyanin-rich on colonic cancer and nontumorigenic colonic cell growth. Journal of Agricultural and Food Chemistry 2004 52 20 6122 6128 2-s2.0-4744364585 10.1021/jf049517a
38. Hyun J. W., Chung H. S., Cyanidin and malvidin from Oryza sativa cv. heugjinjubyeo mediate cytotoxicity against human monocytic leukemia cells by arrest of G 2/M phase and induction of apoptosis. Journal of Agricultural and Food Chemistry 2004 52 8 2213 2217 2-s2.0-1842682909 10.1021/jf030370h
39. Jin H., Leng Q., Li C., Dietary flavonoid for preventing colorectal neoplasms. Cochrane Database of Systematic Reviews 2012 8 CD009350
40. Huang H. P., Chang Y. C., Wu C. H., Hung C. N., Wang C., Anthocyanin-rich Mulberry extract inhibit the gastric cancer cell growth in vitro and xenograft mice by inducing signals of p38/p53 and c-jun. Food Chemistry 2011 129 4 1703 1709 2-s2.0-80051802279 10.1016/j.foodchem.2011.06.035
41. Tsuda T., Horio F., Osawa T., Cyanidin 3-O- β -D-glucoside suppresses nitric oxide production during a zymosan treatment in rats. Journal of Nutritional Science and Vitaminology 2002 48 4 305 310 2-s2.0-0036702860 (Pubitemid 35333984)
42. Xia X., Ling W., Ma J., Xia M., Hou M., Wang Q., Zhu H., Tang Z., An anthocyanin-rich extract from black rice enhances atherosclerotic plaque stabilization in apolipoprotein E-deficient mice. Journal of Nutrition 2006 136 8 2220 2225 2-s2.0-33746652574 (Pubitemid 44156828)
43. Jennings A., Welch A. A., Fairweather-Tait S. J., Higher anthocyanin intake is associated with lower arterial stiffness and central blood pressure in women. The American Journal of Clinical Nutrition 2012 96 4 781 788
44. Hassellund S. S., Flaa A., Kjeldsen S. E., Seljeflot I., Karlsen A., Erlund I., Rostrup M., Effects of anthocyanins on cardiovascular risk factors and inflammation in pre-hypertensive men: a double-blind randomized placebo-controlled crossover study. Journal of Human Hypertension 2013 27 2 100 106 2-s2.0-84856978006 10.1038/jhh.2012.4
45. Ghosh D., Konishi T., Anthocyanins and anthocyanin-rich extracts: role in diabetes and eye function. Asia Pacific Journal of Clinical Nutrition 2007 16 2 200 208 2-s2.0-34248598665 (Pubitemid 46750746)
46. Kang M. K., Li J., Kim J. L., Purple corn anthocyanins inhibit diabetes-associated glomerular monocyte activation and macrophage infiltration. American Journal of Physiology Renal Physiology 2012 303 7 F1060 F1069
47. Nam S. H., Choi S. P., Kang M. Y., Koh H. J., Kozukue N., Friedman M., Antioxidative activities of bran extracts from twenty one pigmented rice cultivars. Food Chemistry 2006 94 4 613 620 2-s2.0-24044457330 10.1016/j.foodchem.2004.12.010 (Pubitemid 41219776)
48. Philpott M., Gould K. S., Lim C., Ferguson L. R., In situ and in vitro antioxidant activity of sweetpotato anthocyanins. Journal of Agricultural and Food Chemistry 2004 52 6 1511 1513 2-s2.0-1642290919 10.1021/jf034593j
49. Wang Y., Chen X., Zhang Y., Chen X., Antioxidant activities and major anthocyanins of myrobalan plum (Prunus cerasifera Ehrh.). Journal of Food Science 2012 77 4 C388 C393 2-s2.0-84860000137 10.1111/j.1750-3841.2012.02624.x
50. Chen S. J., Chung J. G., Chung Y. C., Chou S. T., In vitro antioxidant and antiproliferative activity of the stem extracts from graptopetalum paraguayense. American Journal of Chinese Medicine 2008 36 2 369 383 2-s2.0-44049106411 10.1142/S0192415X08005837 (Pubitemid 351712442)
51. Ho Y. L., Huang S. S., Deng J. S., Lin Y., Chang Y., Huang G., In vitro antioxidant properties and total phenolic contents of wetland medicinal plants in Taiwan. Botanical Studies 2012 53 1 55 66 2-s2.0-84857866387
52. Miyazawa M., Oshima T., Koshio K., Itsuzaki Y., Anzai J., Tyrosinase inhibitor from black rice bran. Journal of Agricultural and Food Chemistry 2003 51 24 6953 6956 2-s2.0-0242691889 10.1021/jf030388s
53. Yamakoshi J., Otsuka F., Sano A., Tokutake S., Saito M., Kikuchi M., Kubota Y., Lightening effect on ultraviolet-induced pigmentation of Guinea pig skin by oral administration of a proanthocyanidin-rich extract from grape seeds. Pigment Cell Research 2003 16 6 629 638 2-s2.0-0345276519 10.1046/j.1600-0749. 2003.00093.x (Pubitemid 37466294)
54. Gómez-Cordovés C., Bartolomé B., Vieira W., Virador V. M., Effects of wine phenolics and sorghum tannins on tyrosinase activity and growth of melanoma cells. Journal of Agricultural and Food Chemistry 2001 49 3 1620 1624 2-s2.0-0034832742 10.1021/jf001116h (Pubitemid 32885002)
55. Hanamura T., Uchida E., Aoki H., Skin-lightening effect of a polyphenol extract from acerola (Malpighia emarginata DC.) fruit on UV-induced pigmentation. Bioscience, Biotechnology and Biochemistry 2008 72 12 3211 3218 2-s2.0-58149099195 10.1271/bbb.80421
56. Dell'Agli M., Galli G. V., Vrhovsek U., Mattivi F., Bosisio E., In vitro inhibition of human cGMP-specific phosphodiesterase-5 by polyphenols from red grapes. Journal of Agricultural and Food Chemistry 2005 53 6 1960 1965 2-s2.0-15444367229 10.1021/jf048497+ (Pubitemid 40395760)
57. Hattori M., Sugino E., Minoura K., In Y., Sumida M., Taniguchi T., Tomoo K., Ishida T., Different inhibitory response of cyanidin and methylene blue for filament formation of tau microtubule-binding domain. Biochemical and Biophysical Research Communications 2008 374 1 158 163 2-s2.0-47749108256 10.1016/j.bbrc.2008.07.001
58. Shih P. H., Chan Y. C., Liao J. W., Wang M. F., Yen G. C., Antioxidant and cognitive promotion effects of anthocyanin-rich mulberry (Morus atropurpurea L.) on senescence-accelerated mice and prevention of Alzheimer's disease. Journal of Nutritional Biochemistry 2010 21 7 598 605 2-s2.0-77953808751 10.1016/j.jnutbio.2009.03.008
59. Zuo Y., Peng C., Liang Y., Black rice extract extends the lifespan of fruit flies. Food & Function 2012 3 12 1271 1279 10.1039/c2fo30135k
60. Shih P. H., Wu C. H., Yeh C. T., Yen G. C., Protective effects of anthocyanins against amyloid β -peptide-induced damage in neuro-2A Cells. Journal of Agricultural and Food Chemistry 2011 59 5 1683 1689 2-s2.0-79952129119 10.1021/jf103822h
61. Huang H. J., Yu H. W., Chen C. Y., Hsu C., Chen H., Lee K., Tsai F., Chen C. Y., Current developments of computer-aided drug design. Journal of the Taiwan Institute of Chemical Engineers 2010 41 6 623 635 2-s2.0-78649451630 10.1016/j.jtice.2010.03.017
62. Chen C. Y. C., A novel integrated framework and improved methodology of computer-aided drug design. Current Topics in Medicinal Chemistry 2013 13 9 965 988
63. Chen C. Y., A novel integrated framework and improved methodology of computer-aided drug design. Current Topics in Medicinal Chemistry 2013 13 9 965 988
64. Yoshiyama Y., Higuchi M., Zhang B., Huang S., Iwata N., Saido T., Maeda J., Suhara T., Trojanowski J. Q., Lee V. M.-Y., Synapse loss and microglial activation precede tangles in a P301S tauopathy mouse model. Neuron 2007 53 3 337 351 2-s2.0-33846538660 10.1016/j.neuron.2007.01.010 (Pubitemid 46161268)
65. Dineley K. T., Kayed R., Neugebauer V., Fu Y., Zhang W., Reese L. C., Taglialatela G., Amyloid- β oligomers impair fear conditioned memory in a calcineurin-dependent fashion in mice. Journal of Neuroscience Research 2010 88 13 2923 2932 2-s2.0-77957233071 10.1002/jnr.22445
66. Spires-Jones T. L., Kay K., Matsouka R., Rozkalne A., Betensky R. A., Hyman B. T., Calcineurin inhibition with systemic FK506 treatment increases dendritic branching and dendritic spine density in healthy adult mouse brain. Neuroscience Letters 2011 487 3 260 263 2-s2.0-78650518914 10.1016/j.neulet. 2010.10.033
67. Rozkalne A., Hyman B. T., Spires-Jones T. L., Calcineurin inhibition with FK506 ameliorates dendritic spine density deficits in plaque-bearing Alzheimer model mice. Neurobiology of Disease 2011 41 3 650 654 2-s2.0-79151481130 10.1016/j.nbd.2010.11.014
68. Trojanowski J. Q., Duff K., Fillit H., Koroshetz W., Kuret J., Murphy D., Refolo L., New directions for frontotemporal dementia drug discovery. Alzheimer's and Dementia 2008 4 2 89 93 2-s2.0-40649124747 10.1016/j.jalz.2007. 06.001 (Pubitemid 351373199)
69. Starzl T. E., Fung J., Venkataramman R., Todo S., Demetris A. J., Jain A., FK 506 for liver, kidney, and pancreas transplantation. The Lancet 1989 2 8670 1000 1004 2-s2.0-0024419167 (Pubitemid 19257914)
70. Shapiro R., Fung J. J., Jain A. B., Parks P., Todo S., Starzl T. E., The side effects of FK 506 in humans. Transplantation Proceedings 1990 22 1 35 36 2-s2.0-0025357395 (Pubitemid 20112747)
71. Mohebbi N., Mihailova M., Wagner C. A., The calcineurin inhibitor FK506 (tacrolimus) is associated with transient metabolic acidosis and altered expression of renal acid-base transport proteins. American Journal of Physiology-Renal Physiology 2009 297 2 F499 F509 2-s2.0-68049109460 10.1152/ajprenal.90489.2008
72. Haddad E. M., McAlister V. C., Renouf E., Malthaner R., Kjaer M. S., Gluud L. L., Cyclosporin versus tacrolimus for liver transplanted patients. Cochrane Database of Systematic Reviews 2006 4 CD005161 2-s2.0-39049180898
73. Ochiai T., Nagata M., Nakajima K., Suzuki T., Sakamoto K., Enomoto K., Gunji Y., Uematsu T., Goto T., Hori S., Kenmochi T., Nakagouri T., Asano T., Isono K., Hamaguchi K., Tsuchida H., Nakahara K., Inamura N., Goto T., Studies of the effects of FK506 on renal allografting in the beagle dog. Transplantation 1987 44 6 729 733 2-s2.0-0023587963 (Pubitemid 18034268)
74. Liao W.-L., Tsai F.-J., Personalized medicine: a paradigm shift in healthcare. BioMedicine 2013 3 2 66 72
75. Tsai F.-J., Biomedicine brings the future nearer. Biomedicine 2011 2-s2.0-80955173849 10.1016/j.biomed.2011.10.007
76. Tsai F.-J., Rare diseases: a mysterious puzzle. BioMedicine 2013 3 2 65 10.1016/j.biomed.2013.04.004
77. Wang C.-H., Lin W.-D., Tsai F.-J., Craniofacial dysmorphism, what is your diagnosis? BioMedicine 2012 2 2 49 50 2-s2.0-84860555530 10.1016/j.biomed.2012. 04.001
78. Chen C. Y., TCM Database@Taiwan: the world's largest traditional Chinese medicine database for drug screening In Silico. PLoS ONE 2011 6 1 2-s2.0-79251561193 10.1371/journal.pone.0015939 e15939
79. Chen K. C., Chen C. Y. C., Stroke prevention by traditional Chinese medicine? A genetic algorithm, support vector machine and molecular dynamics approach. Soft Matter 2011 7 8 4001 4008 2-s2.0-79953746295 10.1039/c0sm01548b
80. Chen K. C., Sun M. F., Yang S. C., Chang S., Chen H., Tsai F., Chen C. Y., Investigation into potent inflammation inhibitors from traditional Chinese medicine. Chemical Biology and Drug Design 2011 78 4 679 688 2-s2.0-80052619174 10.1111/j.1747-0285.2011.01202.x
81. Tou W. I., Chang S. S., Lee C. C., Chen C. Y., Drug design for neuropathic pain regulation from traditional Chinese medicine. Scientific Reports 2013 3 844
82. Yang S. C., Chang S. S., Chen H., Chen C. Y., Identification of potent EGFR inhibitors from TCM Database@Taiwan. PLoS Computational Biology 2011 7 10 2-s2.0-80055077153 10.1371/journal.pcbi.1002189 e1002189
83. Yang S. C., Chang S. S., Chen C. Y., Identifying HER2 inhibitors from natural products database. PLoS ONE 2011 6 12 2-s2.0-83155183294 10.1371/journal.pone.0028793 e28793
84. Chang S. S., Huang H. J., Chen C. Y. C., Two birds with one stone? Possible dual-targeting H1N1 inhibitors from traditional Chinese medicine. PLoS Computational Biology 2011 7 12 2-s2.0-84855282742 10.1371/journal.pcbi.1002315 e1002315
85. Chang T. T., Sun M. F., Chen H. Y., Tsai F., Fisher M., Lin J., Chen C. Y., Screening from the world's largest TCM database against H1N1 virus. Journal of Biomolecular Structure and Dynamics 2011 28 5 773 786 2-s2.0-79952209193
86. Tsai T. Y., Chang K. W., Chen C. Y., IScreen: World's first cloud-computing web server for virtual screening and de novo drug design based on TCM database@Taiwan. Journal of Computer-Aided Molecular Design 2011 25 6 525 531 2-s2.0-80051545693 10.1007/s10822-011-9438-9
87. Wu B., Li P., Liu Y., Ding Y., Shu C., Ye S., Bartlam M., Shen B., Rao Z., 3D structure of human FK506-binding protein 52: implication for the assembly of the glucocorticoid receptor/Hsp90/immunophilin heterocomplex. Proceedings of the National Academy of Sciences of the United States of America 2004 101 22 8348 8353 2-s2.0-2942593899 10.1073/pnas.0305969101 (Pubitemid 38736578)
88. Wang Y., Bolton E., Dracheva S., Karapetyan K., Shoemaker B. A., Suzek T. O., Wang J., Xiao J., Zhang J., Bryant S. H., An overview of the PubChem BioAssay resource. Nucleic Acids Research 2009 38 1 D255 D266 2-s2.0-75549087817 10.1093/nar/gkp965 gkp965
89. Tou W. I., Chen C. Y., May disordered protein cause serious drug side effect? Drug Discovery Today 2014 19 4 367 372 10.1016/j.drudis.2013.10.020
90. Chen C. Y. C., Tou W. L., How to design a drug for the disordered proteins. Drug Discovery Today 2013 18 19-20 910 915
91. Venkatachalam C. M., Jiang X., Oldfield T., Waldman M., LigandFit: a novel method for the shape-directed rapid docking of ligands to protein active sites. Journal of Molecular Graphics and Modelling 2003 21 4 289 307 2-s2.0-0037212102 10.1016/S1093-3263(02)00164-X (Pubitemid 35441326)
92. Laskowski R. A., Swindells M. B., LigPlot+: multiple ligand-protein interaction diagrams for drug discovery. Journal of Chemical Information and Modeling 2011 51 10 2778 2786 2-s2.0-80054911951 10.1021/ci200227u
93. Brooks B. R., Brooks C. L. III, Mackerell A. D. Jr., Nilsson L., Petrella R. J., Roux B., Won Y., Archontis G., Bartels C., Boresch S., Caflisch A., Caves L., Cui Q., Dinner A. R., Feig M., Fischer S., Gao J., Hodoscek M., Im W., Kuczera K., Lazaridis T., Ma J., Ovchinnikov V., Paci E., Pastor R. W., Post C. B., Pu J. Z., Schaefer M., Tidor B., Venable R. M., Woodcock H. L., Wu X., Yang W., York D. M., Karplus M., CHARMM: the biomolecular simulation program. Journal of Computational Chemistry 2009 30 10 1545 1614 2-s2.0-67650500988 10.1002/jcc.21287
94. Fletcher R., Optimization 1969 New York, NY, USA Academic Press
95. Fletcher R., Reeves C. M., Function minimization by conjugate gradients. Computer Journal 1964 7 2 149 154
96. Peters J. H., de Groot B. L., Ubiquitin dynamics in complexes reveal molecular recognition mechanisms beyond induced fit and conformational selection. PLOS Computational Biology 2012 8 10 e1002704
97. Li P., Ding Y., Wu B., Shu C., Shen B., Rao Z., Structure of the N-terminal domain of human FKBP52. Acta Crystallographica D: Biological Crystallography 2003 59 1 16 22 2-s2.0-0037237891 10.1107/S0907444902017523 (Pubitemid 36117201)
98. Riggs D. L., Cox M. B., Tardif H. L., Hessling M., Buchner J., Smith D. F., Noncatalytic role of the FKBP52 peptidyl-prolyl isomerase domain in the regulation of steroid hormone signaling. Molecular and Cellular Biology 2007 27 24 8658 8669 2-s2.0-37549067731 10.1128/MCB.00985-07
99. Sinars C. R., Cheung-Flynn J., Rimerman R. A., Scammell J. G., Smith D. F., Clardy J., Structure of the large FK506-binding protein FKBP51, an Hsp90-binding protein and a component of steroid receptor complexes. Proceedings of the National Academy of Sciences of the United States of America 2003 100 3 868 873 2-s2.0-0345144024 10.1073/pnas.0231020100 (Pubitemid 36183922)